{
     "PMID": "27411072",
     "OWN": "NLM",
     "STAT": "MEDLINE",
     "DCOM": "20180228",
     "LR": "20180228",
     "IS": "1678-2690 (Electronic) 0001-3765 (Linking)",
     "VI": "88",
     "IP": "3 Suppl",
     "DP": "2016",
     "TI": "Amyloid-beta peptide absence in short term effects on kinase activity of energy metabolism in mice hippocampus and cerebral cortex.",
     "PG": "1829-1840",
     "LID": "10.1590/0001-3765201620150776 [doi] S0001-37652016005009108 [pii]",
     "AB": "Considering that Alzheimer's disease is a prevalent neurodegenerative disease worldwide, we investigated the activities of three key kinases: creatine kinase, pyruvate kinase and adenylate kinase in the hippocampus and cerebral cortex in Alzheimer's disease model. Male adult Swiss mice received amyloid-beta or saline. One day after, mice were treated with blank nanocapsules (17 ml/kg) or meloxicam-loaded nanocapsules (5 mg/kg) or free meloxicam (5 mg/kg). Treatments were performed on alternating days, until the end of the experimental protocol. In the fourteenth day, kinases activities were performed. Amyloid-beta did not change the kinases activity in the hippocampus and cerebral cortex of mice. However, free meloxicam decrease the creatine kinase activity in mitochondrial-rich fraction in the group induced by amyloid-beta, but for the cytosolic fraction, it has raised in the activity of pyruvate kinase activity in cerebral cortex. Further, meloxicam-loaded nanocapsules administration reduced adenylate kinase activity in the hippocampus of mice injected by amyloid-beta. In conclusion we observed absence in short-term effects in kinases activities of energy metabolism in mice hippocampus and cerebral cortex using amyloid-beta peptide model. These findings established the foundation to further study the kinases in phosphoryltransfer network changes observed in the brains of patients post-mortem with Alzheimer's disease.",
     "FAU": [
          "Ianiski, Francine R",
          "Rech, Virginia C",
          "Nishihira, Vivian S K",
          "Alves, Catiane B",
          "Baldissera, Matheus D",
          "Wilhelm, Ethel A",
          "Luchese, Cristiane"
     ],
     "AU": [
          "Ianiski FR",
          "Rech VC",
          "Nishihira VS",
          "Alves CB",
          "Baldissera MD",
          "Wilhelm EA",
          "Luchese C"
     ],
     "AD": "Programa de Pos-Graduacao em Nanociencias, Centro de Ciencias Tecnologicas, Centro Universitario Franciscano, Rua dos Andradas, 1614, Conjunto I, 97010-032 Santa Maria, RS, Brasil. Programa de Pos-Graduacao em Nanociencias, Centro de Ciencias Tecnologicas, Centro Universitario Franciscano, Rua dos Andradas, 1614, Conjunto I, 97010-032 Santa Maria, RS, Brasil. Programa de Pos-Graduacao em Nanociencias, Centro de Ciencias Tecnologicas, Centro Universitario Franciscano, Rua dos Andradas, 1614, Conjunto I, 97010-032 Santa Maria, RS, Brasil. Programa de Pos-Graduacao em Nanociencias, Centro de Ciencias Tecnologicas, Centro Universitario Franciscano, Rua dos Andradas, 1614, Conjunto I, 97010-032 Santa Maria, RS, Brasil. Departamento de Microbiologia e Parasitologia, Universidade Federal de Santa Maria, Av. Roraima, 1000, Cidade Universitaria, Bairro Camobi, 97105-900 Santa Maria, RS, Brasil. Centro de Ciencias Quimicas, Farmaceuticas e de Alimentos, Universidade Federal de Pelotas, Campus Universitario, s/n, 96160-000 Capao do Leao, RS, Brasil. Centro de Ciencias Quimicas, Farmaceuticas e de Alimentos, Universidade Federal de Pelotas, Campus Universitario, s/n, 96160-000 Capao do Leao, RS, Brasil.",
     "LA": [
          "eng"
     ],
     "PT": [
          "Journal Article"
     ],
     "DEP": "20160711",
     "PL": "Brazil",
     "TA": "An Acad Bras Cienc",
     "JT": "Anais da Academia Brasileira de Ciencias",
     "JID": "7503280",
     "RN": [
          "0 (Amyloid beta-Peptides)",
          "EC 2.7.1.40 (Pyruvate Kinase)",
          "EC 2.7.3.2 (Creatine Kinase)",
          "EC 2.7.4.3 (Adenylate Kinase)"
     ],
     "SB": "IM",
     "MH": [
          "Adenylate Kinase/*metabolism",
          "Alzheimer Disease/*metabolism",
          "*Amyloid beta-Peptides",
          "Animals",
          "Cerebral Cortex/*enzymology",
          "Creatine Kinase/*metabolism",
          "*Energy Metabolism",
          "Hippocampus/*enzymology",
          "Humans",
          "Male",
          "Mice",
          "Pyruvate Kinase/*metabolism"
     ],
     "EDAT": "2016/07/15 06:00",
     "MHDA": "2018/03/01 06:00",
     "CRDT": [
          "2016/07/14 06:00"
     ],
     "PHST": [
          "2015/10/20 00:00 [received]",
          "2016/01/14 00:00 [accepted]",
          "2016/07/14 06:00 [entrez]",
          "2016/07/15 06:00 [pubmed]",
          "2018/03/01 06:00 [medline]"
     ],
     "AID": [
          "S0001-37652016005009108 [pii]",
          "10.1590/0001-3765201620150776 [doi]"
     ],
     "PST": "epublish",
     "SO": "An Acad Bras Cienc. 2016 Jul 11;88(3 Suppl):1829-1840. doi: 10.1590/0001-3765201620150776. Print 2016.",
     "term": "hippocampus"
}